UB Paderborn / Katalog / Suche / in CDI

Exendin‐4‐based imaging in insulinoma localization: Systematic review and meta‐analysis

Clinical endocrinology (Oxford), 2021-08, Vol.95 (2), p.354-364

2021

Link zum Volltext

Verfügbarkeit prüfen

A pH‐Triggered Self‐Unpacking Capsule Containing Zwitterionic Hydrogel‐Coated MOF Nanoparticles for Efficient Oral Exendin‐4 Delivery

Advanced materials (Weinheim), 2021-08, Vol.33 (32), p.e2102044-n/a

2021

Link zum Volltext

Verfügbarkeit prüfen

Exendin‐4 protects the hearts of rats from ischaemia/reperfusion injury by boosting antioxidant levels and inhibition of JNK/p66Shc/NADPH axis

Clinical and experimental pharmacology & physiology, 2020-07, Vol.47 (7), p.1240-1253

2020

Link zum Volltext

Verfügbarkeit prüfen

Liposome-encapsulated clodronate specifically depletes spinal microglia and reduces initial neuropathic pain

Biochemical and biophysical research communications, 2018-05, Vol.499 (3), p.499-505

2018

Link zum Volltext

Verfügbarkeit prüfen

Paraventricular Thalamic Control of Food Intake and Reward: Role of Glucagon-Like Peptide-1 Receptor Signaling

Neuropsychopharmacology (New York, N.Y.), 2017-11, Vol.42 (12), p.2387-2397

2017

Link zum Volltext

Verfügbarkeit prüfen

The structure and function of the glucagon‐like peptide‐1 receptor and its ligands

British journal of pharmacology, 2012-05, Vol.166 (1), p.27-41

Donnelly, Dan

2012

Link zum Volltext

Verfügbarkeit prüfen

The glucagon-like peptide 1 (GLP-1) analogue, exendin-4, decreases the rewarding value of food: a new role for mesolimbic GLP-1 receptors

The Journal of neuroscience, 2012-04, Vol.32 (14), p.4812-4820

2012

Link zum Volltext

Verfügbarkeit prüfen

Exendin‐4, a Glucagon‐Like Peptide‐1 Receptor Agonist, Prevents Osteopenia by Promoting Bone Formation and Suppressing Bone Resorption in Aged Ovariectomized Rats

Journal of bone and mineral research, 2013-07, Vol.28 (7), p.1641-1652

2013

Link zum Volltext

Verfügbarkeit prüfen

The cardioprotective effect of melatonin and exendin-4 treatment in a rat model of cardiorenal syndrome

Journal of pineal research, 2016-11, Vol.61 (4), p.438-456

2016

Link zum Volltext

Verfügbarkeit prüfen

The food intake-suppressive effects of glucagon-like peptide-1 receptor signaling in the ventral tegmental area are mediated by AMPA/kainate receptors

American journal of physiology: endocrinology and metabolism, 2013-12, Vol.305 (11), p.E1367-E1374

2013

Link zum Volltext

Verfügbarkeit prüfen

Neuroprotective and neurotrophic actions of glucagon‐like peptide‐1: an emerging opportunity to treat neurodegenerative and cerebrovascular disorders

British journal of pharmacology, 2012-07, Vol.166 (5), p.1586-1599

2012

Link zum Volltext

Verfügbarkeit prüfen

Exendin‐4 from Heloderma suspectum venom: From discovery to its latest application as type II diabetes combatant

Basic & clinical pharmacology & toxicology, 2019-05, Vol.124 (5), p.513-527

2019

Link zum Volltext

Verfügbarkeit prüfen

Exendin‐4‐based imaging in endogenous hyperinsulinemic hypoglycaemia cohort: A tertiary Endocrine centre experience

Clinical endocrinology (Oxford), 2020-12, Vol.93 (6), p.678-686

2020

Link zum Volltext

Verfügbarkeit prüfen

The metabolite GLP‐1 (9‐36) is neuroprotective and anti‐inflammatory in cellular models of neurodegeneration

Journal of neurochemistry, 2021-12, Vol.159 (5), p.867-886

2021

Link zum Volltext

Verfügbarkeit prüfen

Mechanisms of action of glucagon-like peptide 1 in the pancreas

Pharmacology & therapeutics (Oxford), 2007-03, Vol.113 (3), p.546-593

2007

Link zum Volltext

Verfügbarkeit prüfen

Glucagon-like peptide-1 in the rat brain: Distribution of expression and functional implication

Journal of comparative neurology (1911), 2013-07, Vol.521 (10), p.2235-2261

2013

Link zum Volltext

Verfügbarkeit prüfen

Neuroprotective effects of the novel GLP-1 long acting analogue semaglutide in the MPTP Parkinson's disease mouse model

Neuropeptides (Edinburgh), 2018-10, Vol.71, p.70-80

2018

Link zum Volltext

Verfügbarkeit prüfen

Utility of 68Ga‐DOTA‐Exendin‐4 positron emission tomography–computed tomography imaging in distinguishing between insulinoma and nesidioblastosis in patients with confirmed endogenous hyperinsulinaemic hypoglycaemia

Internal medicine journal, 2021-10, Vol.51 (10), p.1657-1664

2021

Link zum Volltext

Verfügbarkeit prüfen

Cigarette smoking, type 2 diabetes mellitus, and glucagon-like peptide-1 receptor agonists as a potential treatment for smokers with diabetes: An integrative review

Diabetes research and clinical practice, 2019-03, Vol.149, p.78-88

2019

Link zum Volltext

Verfügbarkeit prüfen

Effects of the GLP-1 Agonist Exendin-4 on Intravenous Ethanol Self-Administration in Mice

Alcoholism, clinical and experimental research, 2016-10, Vol.40 (10), p.2247-2252

2016

Link zum Volltext

Verfügbarkeit prüfen

Exendin‐4 enhances osteogenic differentiation of adipose tissue mesenchymal stem cells through the receptor activator of nuclear factor‐kappa B and osteoprotegerin signaling pathway

Journal of cellular biochemistry, 2022-05, Vol.123 (5), p.906-920

2022

Link zum Volltext

Verfügbarkeit prüfen

GLP-1 Receptor Activation Abrogates β-Cell Dysfunction by PKA Cα-Mediated Degradation of Thioredoxin Interacting Protein

Frontiers in pharmacology, 2019-10, Vol.10, p.1230-1230

2019

Link zum Volltext

Verfügbarkeit prüfen

Optoacoustic Imaging of Glucagon-like Peptide-1 Receptor with a Near-Infrared Exendin-4 Analog

Journal of Nuclear Medicine, 2021-06, Vol.62 (6), p.839-848

2021

Link zum Volltext

Verfügbarkeit prüfen

Challenges in detecting disease modification in Parkinson's disease clinical trials

Parkinsonism & related disorders, 2016-11, Vol.32, p.1-11

2016

Link zum Volltext

Verfügbarkeit prüfen

The glucagon-like peptide 1 analogue, exendin-4, attenuates the rewarding properties of psychostimulant drugs in mice

PloS one, 2013-07, Vol.8 (7), p.e69010

2013

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Exendin‐4‐based imaging in insulinoma localization: Systematic review and meta‐analysis

A pH‐Triggered Self‐Unpacking Capsule Containing Zwitterionic Hydrogel‐Coated MOF Nanoparticles for Efficient Oral Exendin‐4 Delivery

Exendin‐4 protects the hearts of rats from ischaemia/reperfusion injury by boosting antioxidant levels and inhibition of JNK/p66Shc/NADPH axis

Liposome-encapsulated clodronate specifically depletes spinal microglia and reduces initial neuropathic pain

Paraventricular Thalamic Control of Food Intake and Reward: Role of Glucagon-Like Peptide-1 Receptor Signaling

The structure and function of the glucagon‐like peptide‐1 receptor and its ligands

The glucagon-like peptide 1 (GLP-1) analogue, exendin-4, decreases the rewarding value of food: a new role for mesolimbic GLP-1 receptors

Exendin‐4, a Glucagon‐Like Peptide‐1 Receptor Agonist, Prevents Osteopenia by Promoting Bone Formation and Suppressing Bone Resorption in Aged Ovariectomized Rats

The cardioprotective effect of melatonin and exendin-4 treatment in a rat model of cardiorenal syndrome

The food intake-suppressive effects of glucagon-like peptide-1 receptor signaling in the ventral tegmental area are mediated by AMPA/kainate receptors

Neuroprotective and neurotrophic actions of glucagon‐like peptide‐1: an emerging opportunity to treat neurodegenerative and cerebrovascular disorders

Exendin‐4 from Heloderma suspectum venom: From discovery to its latest application as type II diabetes combatant

Exendin‐4‐based imaging in endogenous hyperinsulinemic hypoglycaemia cohort: A tertiary Endocrine centre experience

The metabolite GLP‐1 (9‐36) is neuroprotective and anti‐inflammatory in cellular models of neurodegeneration

Mechanisms of action of glucagon-like peptide 1 in the pancreas

Glucagon-like peptide-1 in the rat brain: Distribution of expression and functional implication

Neuroprotective effects of the novel GLP-1 long acting analogue semaglutide in the MPTP Parkinson's disease mouse model

Utility of 68Ga‐DOTA‐Exendin‐4 positron emission tomography–computed tomography imaging in distinguishing between insulinoma and nesidioblastosis in patients with confirmed endogenous hyperinsulinaemic hypoglycaemia

Cigarette smoking, type 2 diabetes mellitus, and glucagon-like peptide-1 receptor agonists as a potential treatment for smokers with diabetes: An integrative review

Effects of the GLP-1 Agonist Exendin-4 on Intravenous Ethanol Self-Administration in Mice

Exendin‐4 enhances osteogenic differentiation of adipose tissue mesenchymal stem cells through the receptor activator of nuclear factor‐kappa B and osteoprotegerin signaling pathway

GLP-1 Receptor Activation Abrogates β-Cell Dysfunction by PKA Cα-Mediated Degradation of Thioredoxin Interacting Protein

Optoacoustic Imaging of Glucagon-like Peptide-1 Receptor with a Near-Infrared Exendin-4 Analog

Challenges in detecting disease modification in Parkinson's disease clinical trials

The glucagon-like peptide 1 analogue, exendin-4, attenuates the rewarding properties of psychostimulant drugs in mice

Suchergebnisse filtern